Boston Scientific Reports Strong Q2 2025 Performance with Highlights across Multiple Segments Boston Scientific Corporation revealed impressive Q2 2025 financial results, highlighting significant growth in net sales and earnings compared to last year.

Boston Scientific Reports Strong Q2 2025 Performance with Highlights across Multiple Segments #USA #Marlborough #Boston_Scientific #FARAPULSE #TIVUS

Boston Scientific Achieves Impressive Growth in Q1 2025 Financial Results Boston Scientific Corporation reports a robust 20.9% increase in net sales for Q1 2025, driven by strong product demand and strategic clinical advancements.

Boston Scientific Achieves Impressive Growth in Q1 2025 Financial Results #USA #Marlborough #Boston_Scientific #FARAFLEX #TIVUS